- Separace deferipronu a jeho komplexu se železem pomocí kapilární elektroforézy2008 | Přírodovědecká fakulta
- Deferipron nechrání vůči chronické antracyklinové kardiotoxicitě in vivo2008 | Ústřední knihovna
- Deferipron nechrání vůči chronické antracyklinové kardiotoxicitě in vivo2008 | Lékařská fakulta v Hradci Králové
- Použití CE a MEKC pro separaci deferipronu a jeho chelatu se železem2007 | Přírodovědecká fakulta
- Trial of Deferiprone in Parkinson's Disease2022 | 1. lékařská fakulta
- A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes2013 | Publikace bez příslušnosti k fakultě
- The effect of the oral iron chelator deferiprone on the liver damage induced by tamoxifen in female rats2011 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- The effect of iron(III) on the activity of selenoenzymes and oxidative damage in the liver of rats. Interaction with natural antioxidants and deferiprone2010 | Lékařská fakulta v Plzni
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | 1. lékařská fakulta
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | Publikace bez příslušnosti k fakultě
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo2008 | Farmaceutická fakulta v Hradci Králové
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo2008 | Lékařská fakulta v Hradci Králové
- Effect of deferiprone on lead-induced oxidative damage and trace element level in rats2001 | Lékařská fakulta v Plzni
- Can deferiprone (a novel intracellular iron chelator) afford significant protection against chronic anthracycline cardiotoxicity in vivo?Publikace bez příslušnosti k fakultě
- Effect of deferiprone on tamoxifen-induced liver injury in rats2009 | Lékařská fakulta v Plzni
- Tamoxifen hepatotoxicity - interaction with resveratrol and deferiprone in rats2009 | Lékařská fakulta v Plzni
- Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration : a randomised, double-blind, controlled trial and an open-label extension study2019 | 1. lékařská fakulta
- The influence of deferiprone (L 1) and deferoxamine on the level of essential elements in mice1999 | Lékařská fakulta v Plzni, Ústřední knihovna
- Oxidative damage caused by iron loading. The influence of deferoxamine and deferiprone2001 | Lékařská fakulta v Plzni, Ústřední knihovna
- The influence of deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice2002 | Lékařská fakulta v Plzni, Ústřední knihovna
- Effect of deferiprone on lead-induced oxidative damage and trace element level in ratsPublikace bez příslušnosti k fakultě
- Effect of deferiprone on the changes in lead-induced oxidative damage and trace element level in rats2001 | Lékařská fakulta v Plzni
- Toxicological and pharmacological effects of l-deferiprone. Prospects for improving its efficacy and safety by new therapeutic interventions1997 | Lékařská fakulta v Plzni
- The effect of the oral iron chelator deferiprone on the liver damage induced by tamoxifen in female rats2009 | Lékařská fakulta v Plzni
- The effect of iron (FE III) on the activity of selenoenzymes and oxidative damage in rats - interaction with natural antioxidants and deferiprone2008 | Lékařská fakulta v Plzni
- Comparison of various iron chelators used in clinical practice as protecting agents against catecholamine-induced oxidative injury and cardiotoxicity2011 | Farmaceutická fakulta v Hradci Králové
- Farmakologická kardioprotekce pomocí chelátorů železa a antracyklinová kardiotoxicita +1Publikace bez příslušnosti k fakultě
- Neurodegeneration with brain iron accumulation2012 | 1. lékařská fakulta
- Erythropoietin administration may potentiate mobilization of storage iron in patients on oral iron chelation therapy2006 | 1. lékařská fakulta
